Page 139 - LIBRO DE PSICOFARMACOLOGÍA

Capítulo 7: Fármacos Antidemencia

BIBLIOGRAFÍA

Haefely W. Benzodiazepines. Mechanisms of action. En: Antiepileptic Drugs. 3.a ed. RH
Levy, FE Dreifuss, RH Mattson, BS Meldrum y JK Penry, eds. Raven Press. New

York 1989; pp 721-734.

Hansten PD, Horn JR. Drug Interactions & Updates. A Clinical Perspective and Analysis of

Current Developments. Applied Therapeutics Inc. Lea & Fabiger. Philadelphia 1990;
517 pp.

Harrington TM y cols. An open study examining the diagnosis of anxiety and the use of

buspirone in a primary care environment. Drug Invest 1989; 1: 3-10.

Heller AH y cols. Ipsapirone: Evidence for efficacy in depression.Psychopharmacol. Bull

1990; 26: 219-222.

Insel TR, Winslow JT. Neurobiology of obsessive-compulsive disorder: A review. En:

Biological Psychiatry. G Racagni, N Brunello y T Fukuda, eds. Excerpta Medica.
Amsterdam 1991; vol I: pp 664-667.

Ladder M, Morton S. Anxiolytics and withdrawal signs: Comparative studies of alpidem and

benzodiazepines. En: Biológica Psychiatr. G Racagni, N Brunello y T Fukuda, eds.
Excerpta Medica. Amsterdam1991; vol I: pp 693-695.

Langer SZ, Arbela S. Selectivity for omega receptor subtypes as strategy for a novel approach

in the development of anxiolytic drugs. En: Biológica Psychiatr. G Racagni, N
Brunello y TL Fukuda, eds. Excerpta Medica. Amsterdam 1991; vol 1: 683-685.

Leibowitz y cols. Phenalgine and atenolol in social phobia. Psychopharmacology Bull 1990;
26: 123-125.

Morelli PL. On the therapeutic action of alpidem in anxiety disorders: An overview of the
European data. Pharmacy psychiatry 1990; 23 (supply III): 129-134.

Morelli PL. Pharmacological treatment of anxiety in the elderly: New perspectives. En:

Biological Psychiatry. G Racagni, N Brunello y T

137